Search research articles
Contact Us
Filters
Showing results (241-250 of 307) with videos related to
Page
of 31
Sort By:
Plos One
|
December 9, 2014
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches
Berna C Özdemir, Janine Hensel, Chiara Secondini, et al.
The Prostate
|
July 3, 1998
Workgroup 2: human xenograft models of prostate cancer
M E Stearns, J L Ware, D B Agus, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 16, 2025
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response
Juening Kang, Panagiotis Chouvardas, Andrew Maalouf, et al.
Urologic Oncology
|
September 14, 2014
Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice
Bas W G van Rhijn, James W Catto, Peter J Goebell, et al.
The Journal of Urology
|
August 19, 2011
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study
Pascal Zehnder, Urs E Studer, Eila C Skinner, et al.
International Journal of Cancer
|
February 21, 2009
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
Spasenija Savic, Inti Zlobec, George N Thalmann, et al.
Scientific Reports
|
February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy
Bernhard Kiss, Alexander W Wyatt, James Douglas, et al.
Cancer Research
|
May 21, 2013
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression
Nicole Longoni, Manuela Sarti, Domenico Albino, et al.
Frontiers in Cell and Developmental Biology
|
December 21, 2017
ALK1Fc Suppresses the Human Prostate Cancer Growth in <i>in Vitro</i> and <i>in Vivo</i> Preclinical Models
Letizia Astrologo, Eugenio Zoni, Sofia Karkampouna, et al.
European Urology
|
March 29, 2014
Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy
Cyrill A Rentsch, Frédéric D Birkhäuser, Claire Biot, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 307) with videos related to
Sort By:
Page
of 31
Plos One
|
December 9, 2014
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches
Berna C Özdemir, Janine Hensel, Chiara Secondini, et al.
The Prostate
|
July 3, 1998
Workgroup 2: human xenograft models of prostate cancer
M E Stearns, J L Ware, D B Agus, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 16, 2025
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug response
Juening Kang, Panagiotis Chouvardas, Andrew Maalouf, et al.
Urologic Oncology
|
September 14, 2014
Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice
Bas W G van Rhijn, James W Catto, Peter J Goebell, et al.
The Journal of Urology
|
August 19, 2011
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study
Pascal Zehnder, Urs E Studer, Eila C Skinner, et al.
International Journal of Cancer
|
February 21, 2009
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
Spasenija Savic, Inti Zlobec, George N Thalmann, et al.
Scientific Reports
|
February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy
Bernhard Kiss, Alexander W Wyatt, James Douglas, et al.
Cancer Research
|
May 21, 2013
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression
Nicole Longoni, Manuela Sarti, Domenico Albino, et al.
Frontiers in Cell and Developmental Biology
|
December 21, 2017
ALK1Fc Suppresses the Human Prostate Cancer Growth in <i>in Vitro</i> and <i>in Vivo</i> Preclinical Models
Letizia Astrologo, Eugenio Zoni, Sofia Karkampouna, et al.
European Urology
|
March 29, 2014
Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy
Cyrill A Rentsch, Frédéric D Birkhäuser, Claire Biot, et al.
Page
of 31